Case Reports in Gastrointestinal Medicine

Case Reports in Gastrointestinal Medicine / 2018 / Article

Case Report | Open Access

Volume 2018 |Article ID 8087659 | 7 pages | https://doi.org/10.1155/2018/8087659

Blue Rubber Bleb Nevus Syndrome with Long-Term Follow-Up: A Case Report and Review of the Literature

Academic Editor: Chia-Tung Shun
Received09 Aug 2018
Accepted06 Nov 2018
Published25 Nov 2018

Abstract

Blue rubber bleb nevus syndrome (BRBNS) is a rare disease in which venous malformations (VMs) involve any body organ, most commonly the skin and the gastrointestinal (GI) tract. Treatment of BRBNS aims at preserving the GI tract as much as possible. Although there are several dozen case reports about BRBNS that describe short-term clinical courses, a few provide an account of long-term clinical course. Here, we report a case of BRBNS in a girl that required multiple abdominal surgeries due to the GI VMs and a recurrence at an interval of 14 years. The preferred approach for gastrointestinal VMs involves the complete resection of all lesions without residual VMs. It is important to bear in mind the possibility of delayed recurrence of GI VMs after surgical or endoscopic treatment.

1. Introduction

Blue rubber bleb nevus syndrome (BRBNS) is a rare condition, characterized by multiple venous malformations (VMs) of the skin and gastrointestinal (GI) tract [1, 2]. The GI lesions could cause abundant bleeding and lead to severe anemia. If GI bleeding becomes uncontrollable by conservative treatment, endoscopic or surgical intervention is required. In previous reports, short-term postoperative courses were mostly uneventful; however, some cases had prolonged courses owing to residual lesions or recurrence.

We report the case of BRBNS with GI lesions involving long-term follow-up and multiple surgical treatments. We also provide a brief review of the literature regarding long-term follow-up of GI lesions of BRBNS treated endoscopically or surgically.

2. Case Presentation

A 19-year-old girl was admitted to our hospital for surgery with a 15-year history of GI bleeding associated with BRBNS. She had repeated episodes of resections of hemangiolymphangiomas on the right thoracic wall from 3 months to 3 years of age. At 4 years of age, she presented with a few cutaneous small VMs on the feet; hematological examination revealed persistent anemia and positive fecal occult blood. Colonoscopy revealed a VM on the right colon. She underwent an exploratory laparotomy at 5 years of age. Multiple VMs were identified (Figure 1): 1 on the lesser curvature of the stomach, 7 on various parts of the small intestine, 1 on the hepatic flexure of the colon, and 1 on the liver. Intestinal lesions were resected, and gastric and hepatic lesions were left untreated to avoid injury to surrounding organs. The pathological finding was cavernous hemangioma, so she was diagnosed with BRBNS. Four months later, she suffered superior mesenteric artery thrombosis and underwent partial resection of the small intestine. Since then, although mild anemia persisted, it was treatable by oral iron replacement therapy, and the clinical course was uneventful for 10 years.

At 15 years of age, the anemia got slightly worse. Hematological examination revealed that Hemoglobin (Hb) level was 7–8 mg/dL. GI endoscopy, including transanal double-balloon endoscopy and capsule endoscopy, and contrast-enhanced computed tomography (CT) revealed multiple VMs on almost the entire GI tract, including the stomach, duodenum, jejunum, ileum, and colon (Figures 2 and 3). VMs were also found in the right pleural space, hepatic hilum, liver, and spleen. An additional finding was a right ovarian cyst. Anemia and GI bleeding became more severe despite the administration of a β-blocker since she was 18. Hematological examination revealed that Hb level was 4 mg/dL. Frequent blood transfusion was prescribed. At 19 years of age, CT revealed an increase in the size of known lesions. In order to control GI bleeding, she underwent the second surgery for GI VMs. We performed resection of all lesions on the stomach and the intestine, partial resection of the small intestine, appendectomy, splenectomy, and right ovarian cystectomy. Enteric lesions were removed through a gastrotomy, 11 enterotomies, and a sigmoid colotomy. Palpation of a lesion on the posterior gastric corpus revealed the absence of transmural involvement, so the lesion was resected above the proper muscular layer. Palpable lesions on the small intestine (Figure 4(a)) were marked with serosal sutures and were exposed by intussuscepting the bowel through enterotomies (Figure 4(b)). For transmural lesions, wedge resection was performed. For the lesions grossly localized in the mucosal layer, small or polypoid lesions were ligated and resected, and elevated lesions were treated with argon plasma coagulation (APC). Intraoperative endoscopy was performed through enterotomies to detect the remaining lesions (Figure 4(c)). The number of the lesions on the small intestine was > 350. Localized dilatation of the small intestine caused by adhesion of the mesentery was found and resected partially to avoid involvement of an adhesive bowel obstruction. A palpable lesion on the sigmoid colon was ligated and resected through colotomy. Although preoperative colonoscopy revealed several other small lesions from the cecum to the sigmoid colon, they were left untreated because colonoscopic treatment would be possible at a later date. The splenic lesion was suspected to invade the tail of the pancreas, so the pancreatic parenchyma was also resected with splenectomy. Operative duration was 11.5 hours. Intraoperative blood loss was 325 mL. Postoperative pancreatic fistula was observed but successfully managed by conservative treatment. Pathology of surgical specimens revealed VMs in the stomach, small intestine, sigmoid colon, and spleen. The splenic lesion was found to invade pancreatic tissue. The right ovarian cyst was found to be a mature teratoma. Postoperative GI endoscopies revealed the remaining VMs on the duodenum and colon. The patient had no bleeding or anemia for 5 years after the surgery.

3. Discussion

BRBNS is a rare disease characterized by multiple VMs in the skin and the GI tract [1, 2]. The characteristic cutaneous lesions consist of deep blue, rubbery blebs, which are easily compressible. Other organs affected include the central nervous system, joints, liver, spleen, lungs, eyes, and urinary tract. If a person has a cutaneous angioma associated with another symptom such as melena, epilepsy, hemoptysis, hematuria, paralysis, or visual disorder, the possibility of BRBNS should be considered. Gastrointestinal and radiological examinations such as endoscopy, CT, and MRI are the main tools for diagnosis. The differential diagnosis of GI hemangiomatosis includes BRBNS, Osler–Weber–Rendu syndrome, Maffucci syndrome, and Klippel–Trenaunay–Weber syndrome [2].

Treatment of BRBNS is directed to the symptom. Gastrointestinal lesions may manifest clinically with chronic continual bleeding. Conservative treatment by oral iron supplementation or blood transfusion is usually sufficient. Pharmacologic treatment to control GI bleeding with agents such as corticosteroids, interferon-α, and β-blocker has been attempted [1, 13, 14], but there is no convincing evidence of durable beneficial effects of any drug treatment. Recently, the mammalian target of rapamycin (mTOR) inhibitor sirolimus has been reported to be effective in reducing VMs related to BRBNS [13, 14]. If surgical intervention is considered, it is important to preserve as much of the GI tract as possible. In some previous reports, resections of long segments were required because of intussusceptions or extensive areas of involvement [15, 16]. Surgical wedge resection and hemangioectomy are reasonable options to control GI bleeding [17]. Combined intraoperative endoscopy is recommended to avoid oversight of small lesions and to avoid unnecessary bowel resection. Endoscopic treatments such as polypectomy, band ligation, clipping, and APC have been reported recently but are controversial. Some investigators describe endoscopic polypectomy or band ligation as involving high risk of perforation or ulceration in patients with transmural lesions. They are convinced that such lesions should be managed by full-thickness wedge resection [11]. We performed ligation or APC for GI VMs localized in the mucosal layer and wedge resection for transmural lesions with no such complications. Endoscopic electrocautery or APC seemed to be useful in treating small VMs; however, surgical resection seemed to be safe for the treatment of transmural large VMs.

There are 91 cases of BRBNS with GI VMs reported in the literature identified from MEDLINE [18]. However, most of those that required endoscopic or surgical treatment for GI VMs and/or related bleeding concerned only first interventions, with either no follow-up or short-term follow-up for 6 months at most. We analyzed cases with short- to long-term follow-up for > 1 year after the initial endoscopic or surgical treatment. There was no recurrence in the cases with short follow-up periods (1–3 years). Conversely, cases with longer follow-up periods (>5 years) included unstable postoperative courses (Table 1) [312]. Such cases with needs of iron supplementation or blood transfusion might have VM lesions left over on the GI tract, causing bleeding (for example, cases 1, 3, and 7). These cases should be closely followed up. There were cases with stable postoperative periods for 5 years after the first treatment (cases 2, 6, 8, 9, and 10); however, some of these cases revealed recurrence and required a second treatment (cases 2 and 6). Our present case also followed a relatively stable clinical course after the first operation, but revealed mild anemia resulting in a second series of bleeding episodes at an interval of 10 years. This case suggests that long-term follow-up is necessary in BRBNS patients even if the early postoperative course is uneventful. Regular imaging studies like CT and endoscopy would be recommended in the course of follow-up. If VMs on the GI tract recur and the bleeding from the lesions occurs again hereafter, the treatment aims at preserving the GT tract as much as possible. Medical management would have priority over the surgical bowel resection.


No.YearSexAge at onsetAge at treatmentSites of lesionsTreatmentOutcomefollow up period from the 1st / last treatment (year)

1 2001 [3] F00right colectomy 37 / —
0–6partial gastrectomy, small bowel resection, total colectomyblood transfusions required
34–37small intestine, rectumendoscopic sclerotherapyoral iron, vitamin and caloric supplementation

2 1996 [4] F67intestinesurgical resectionstable for 5 years 25 / 5
13small intestine, colonsurgical resectionstable for 5 years
26duodenum, ileum, colonsurgical resectionstable for 5 years

3 1997 [5] M59stomachendoscopic electrocauteryoral iron supplements and blood transfusions required 21 / 1
23stomach, duodenum, small intestine, colonintraoperative endoscopic polypectomy, surgical resectionstable for 1 year

4 1990 [6] F99whole GI tractendoscopic sclerotherapy (for the upper and lower GI)GI bleeding continued 13 / short period
15whole GI tractsurgical resectionstable for 4 years
19upper and lower GI tractintraoperative endoscopic electrocautery, surgical resectionstable for the short period

5 2013 [7] F112stomachsurgical resection 13 / 3.5
22colonendoscopic ligation and sclerotherapystable for 3.5 year

6 2005 [8] F1919colonendoscopic clippingstable for 5 years 7 / short period
25small intestine, colonendoscopic clipping and polypectomy, surgical resectionstable for the short period

72009 [9]M02stomach, colonendoscopic electrocautery (for the stomach)blood transfusions required for 4 years7

82003 [10]F00colonendoscopic APCstable for 5 years5

92007 [11]F812stomach, small intestine, colonSurgical wedge resection, intraoperative endoscopic sclero-coagulationstable for 5 years5

10 2010 [12] M44stomach, colonendoscopic sclerotherapy 5 / 3
6small intestinesurgical resections through enterotomiesstable for 3 years

11 Our case F45stomach, small intestine, colonsurgical resectionstable for 10 years with oral iron supplementation 19 / 5
19stomach, duodenum, small intestine, colonsurgical resection, APCstable for 5 year

“—” means no data described; GI: gastrointestinal; APC: argon plasma coagulation.

In conclusion, we report a case of BRBNS that required a second surgery for delayed recurrence. Long-term follow-up is important in the BRBNS patients following even successful resections.

Written informed consent was obtained from the patient’s family for publication of this case report.

Conflicts of Interest

The authors declare that there are no conflicts of interest regarding the publication of this article.

Authors’ Contributions

Hideaki Nakajima drafted the manuscript. Naoto Urushihara supervised the writing of the manuscript. Hiroshi Nouso, Naoto Urushihara, Masaya Yamoto, and Hiromu Miyake performed the operation. Hideaki Nakajima, Hiroshi Nouso, Koji Fukumoto, Akinori Sekioka, Akiyoshi Nomura, and Yutaka Yamada contributed to the acquisition and analysis, and interpretation of data. All the authors have read and approved the final manuscript.

Acknowledgments

The authors would like to express their deep appreciation to Dr. Shiro Hasegawa and Dr. Tadaharu Okazaki for performing the first operation and perioperative management of the patient. They also would like to thank Enago for the English language review.

References

  1. C. A. R. Martinez, M. R. Rodrigues, D. T. Sato et al., “Blue Rubber Bleb Nevus Syndrome as a Cause of Lower Digestive Bleeding,” Case Reports in Surgery, vol. 2014, Article ID 683684, 4 pages, 2014. View at: Publisher Site | Google Scholar
  2. X. Tang, J. Gao, X. Yang, and X. Guo, “A 10-year delayed diagnosis of blue rubber bleb nevus syndrome characterized by refractory iron-deficiency anemia,” Medicine, vol. 97, no. 22, p. e10873, 2018. View at: Publisher Site | Google Scholar
  3. R. J. Place, “Blue rubber bleb nevus syndrome: A case report with long-term follow-up,” Military Medicine, vol. 166, no. 8, pp. 728–730, 2001. View at: Publisher Site | Google Scholar
  4. M. M. Carr, C. G. Jamieson, and G. Lal, “Blue rubber bleb nevus syndrome,” Can J Surg, vol. 39, no. 1, pp. 59–62, 1996. View at: Google Scholar
  5. S. Shimada, K. Namikawa, K. Maeda et al., “Endoscopic polypectomy under laparotomy throughout the alimentary tract for a patient with blue rubber bleb nevus syndrome,” Gastrointestinal Endoscopy, vol. 45, no. 5, pp. 423–427, 1997. View at: Publisher Site | Google Scholar
  6. M. Shahed, F. Hagenmuller, Rosch Th. et al., “A 19-year-old female with blue rubber bleb nevus syndrome. Endoscopic laser photocoagulation and surgical resection of gastrointestinal angiomata,” Endoscopy, vol. 22, no. 1, pp. 54–56, 1990. View at: Publisher Site | Google Scholar
  7. W. Guo, Z. Peng, X. Tang, Z. Zhao, and Z. Liu, “Endoscopic management of blue rubber bleb nevus syndrome: A case report,” Experimental and Therapeutic Medicine, vol. 6, no. 5, pp. 1159–1162, 2013. View at: Publisher Site | Google Scholar
  8. M. Kanai, M. Noike, C. Masaki et al., “Severe gastrointestinal bleeding during pregnancy in a case of blue rubber bleb nevus syndrome,” Seminars in Thrombosis and Hemostasis, vol. 31, no. 3, pp. 284–289, 2005. View at: Publisher Site | Google Scholar
  9. L. F. Hansen, V. Wewer, S. A. Pedersen, P. Matzen, and A. Paerregaard, “Severe blue rubber bleb nevus syndrome in a neonate,” European Journal of Pediatric Surgery, vol. 19, no. 1, pp. 47–49, 2009. View at: Publisher Site | Google Scholar
  10. W. T. Ng and C. K. Kong, “Argon plasma coagulation for blue rubber bleb nevus syndrome in a female infant,” European Journal of Pediatric Surgery, vol. 13, no. 2, pp. 137–139, 2003. View at: Publisher Site | Google Scholar
  11. M. Kopáčová, I. Tachecí, J. Koudelka, M. Králová, S. Rejchrt, and J. Bureš, “A new approach to blue rubber bleb nevus syndrome: The role of capsule endoscopy and intra-operative enteroscopy,” Pediatric Surgery International, vol. 23, no. 7, pp. 693–697, 2007. View at: Publisher Site | Google Scholar
  12. E. Marín-Manzano, A. Utrilla López, E. Puras Magallay, C. C. Gimeno, and J. L. Marín-Aznar, “Cervical cystic lymphangioma in a patient with Blue Rubber Bleb Nevus Syndrome: Clinical case report and review of the literature,” Annals of Vascular Surgery, vol. 24, no. 8, pp. 1136–e5, 2010. View at: Publisher Site | Google Scholar
  13. H. Yuksekkaya, O. Ozbek, M. Keser, and H. Toy, “Blue rubber bleb nevus syndrome: Successful treatment with sirolimus,” Pediatrics, vol. 129, no. 4, pp. e1080–e1084, 2012. View at: Publisher Site | Google Scholar
  14. R. Salloum, C. E. Fox, C. R. Alvarez-Allende et al., “Response of Blue Rubber Bleb Nevus Syndrome to Sirolimus Treatment,” Pediatric Blood & Cancer, vol. 63, no. 11, pp. 1911–1914, 2016. View at: Publisher Site | Google Scholar
  15. Y. Wang, X. Zhao, and X. You, “Blue rubber bleb nevus syndrome coexisted with intestinal intussusception: a case report,” The Pan African Medical Journal, vol. 17, p. 212, 2014. View at: Publisher Site | Google Scholar
  16. J. Gonzalez-Hernandez and L. Lizardo-Sanchez, “An Atypical Presentation of Blue Rubber Bleb Nevus Syndrome,” Baylor University Medical Center Proceedings, vol. 29, no. 3, pp. 323-324, 2017. View at: Publisher Site | Google Scholar
  17. S. J. Fishman, C. J. Smithers, J. Folkman et al., “Blue rubber bleb nevus syndrome: Surgical eradication of gastrointestinal bleeding,” Annals of Surgery, vol. 241, no. 3, pp. 523–528, 2005. View at: Publisher Site | Google Scholar
  18. X.-L. Jin, Z.-H. Wang, X.-B. Xiao, L.-S. Huang, and X.-Y. Zhao, “Blue rubber bleb nevus syndrome: A case report and literature review,” World Journal of Gastroenterology, vol. 20, no. 45, pp. 17254–17259, 2014. View at: Publisher Site | Google Scholar

Copyright © 2018 Hideaki Nakajima et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

633 Views | 345 Downloads | 0 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.